Kelly Paul Edward

Insider profile

Performance

Overall performance
3.8

Performance over holding periods
3.8
30 days 90 days 120 days
Average return 43% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
9 100% Buy
34 71% Buy
47 69% Buy
Kelly Paul Edward's trades of Relmada Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
217.58
Quantity 7,221 -17.8%
Value US$4,824,367
Transaction date
Purchase
Price
19.20
Quantity 3,100 +2.5%
Value US$59,520
Transaction date
Purchase
Price
19.15
Quantity 100 +0.1%
Value US$1,915
Transaction date
Purchase
Price
19.10
Quantity 200 +0.2%
Value US$3,820
Transaction date
Purchase
Price
19.08
Quantity 100 +0.1%
Value US$1,908
Transaction date
Purchase
Price
19.07
Quantity 400 +0.3%
Value US$7,628
Transaction date
Purchase
Price
19.04
Quantity 100 +0.1%
Value US$1,904
Transaction date
Purchase
Price
18.99
Quantity 1,000 +0.8%
Value US$18,990
Transaction date
Purchase
Price
1.50
Quantity 100,000 +25.7%
Value US$150,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-11-06 2025-11-05 B Purchase
7,221 -17.8%
217.58
US$4,824,367
7,221 -17.8% 217.58 US$4,824,367
2025-05-20 2025-05-16 B Purchase
10,877 +35.8%
289.98
US$1,530,862
10,877 +35.8% 289.98 US$1,530,862
2024-09-11 2024-09-09 B Purchase
41,016 +8.5%
385.97
US$3,589,460
41,016 +8.5% 385.97 US$3,589,460
2022-04-05 2022-04-04 PlS Planned sale
10,000 -5.1%
30.04
US$300,395
10,000 -5.1% 30.04 US$300,395
2021-03-11 2021-03-09 PlS Planned sale
1,612 -1.0%
36.33
US$58,556
1,612 -1.0% 36.33 US$58,556
2021-03-11 2021-03-09 PlS Planned sale
3,388 -2.0%
35.42
US$119,995
3,388 -2.0% 35.42 US$119,995
2021-02-26 2021-02-24 PlS Planned sale
108 -0.1%
35.58
US$3,843
108 -0.1% 35.58 US$3,843
2021-02-26 2021-02-24 PlS Planned sale
2,463 -1.4%
34.64
US$85,315
2,463 -1.4% 34.64 US$85,315
2021-02-26 2021-02-24 PlS Planned sale
2,429 -1.4%
33.67
US$81,775
2,429 -1.4% 33.67 US$81,775
2021-02-10 2021-02-09 PlS Planned sale
2,069 -1.3%
35.29
US$73,005
2,069 -1.3% 35.29 US$73,005
2021-02-10 2021-02-08 PlS Planned sale
1,500 -0.9%
35.04
US$52,560
1,500 -0.9% 35.04 US$52,560
2021-02-03 2021-02-02 PlS Planned sale
2,315 -1.4%
35.04
US$81,118
2,315 -1.4% 35.04 US$81,118
2021-02-03 2021-02-01 PlS Planned sale
31 -0.0%
35.00
US$1,085
31 -0.0% 35.00 US$1,085
2021-01-29 2021-01-27 PlS Planned sale
168 -0.1%
33.40
US$5,611
168 -0.1% 33.40 US$5,611
2021-01-29 2021-01-27 PlS Planned sale
2,988 -2.0%
32.89
US$98,275
2,988 -2.0% 32.89 US$98,275
2021-01-29 2021-01-27 PlS Planned sale
1,844 -1.2%
31.69
US$58,436
1,844 -1.2% 31.69 US$58,436
2021-01-26 2021-01-26 PlS Planned sale
685 -0.5%
35.16
US$24,085
685 -0.5% 35.16 US$24,085
2021-01-26 2021-01-25 PlS Planned sale
1,300 -0.9%
35.27
US$45,851
1,300 -0.9% 35.27 US$45,851
2021-01-26 2021-01-22 PlS Planned sale
300 -0.2%
36.18
US$10,854
300 -0.2% 36.18 US$10,854
2021-01-26 2021-01-22 PlS Planned sale
1,800 -1.2%
3,543.00
US$6,377,400
1,800 -1.2% 3,543.00 US$6,377,400
2019-10-21 2019-10-18 B Purchase
3,100 +2.5%
19.20
US$59,520
3,100 +2.5% 19.20 US$59,520
2019-10-21 2019-10-18 B Purchase
100 +0.1%
19.15
US$1,915
100 +0.1% 19.15 US$1,915
2019-10-21 2019-10-18 B Purchase
200 +0.2%
19.10
US$3,820
200 +0.2% 19.10 US$3,820
2019-10-21 2019-10-18 B Purchase
100 +0.1%
19.08
US$1,908
100 +0.1% 19.08 US$1,908
2019-10-21 2019-10-18 B Purchase
400 +0.3%
19.07
US$7,628
400 +0.3% 19.07 US$7,628
2019-10-21 2019-10-18 B Purchase
100 +0.1%
19.04
US$1,904
100 +0.1% 19.04 US$1,904
2019-10-21 2019-10-18 B Purchase
1,000 +0.8%
18.99
US$18,990
1,000 +0.8% 18.99 US$18,990
2019-05-15 2019-05-14 B Purchase
100,000 +25.7%
1.50
US$150,000
100,000 +25.7% 1.50 US$150,000